First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.
- DOI
- 10.1111/cts.13742
- Published
- 2024 Mar
- Container
- Clinical and translational science
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/cts.13742,
title = {First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.},
author = {Narayan R and Piérola AA and Donnellan WB and Yordi AM and Abdul-Hay M and Platzbecker U and Subklewe M and Kadia TM and Alonso-Domínguez JM and McCloskey J and Bradford K and Curtis M and Daskalakis N and Guttke C and Safer K and Hiebert B and Murphy J and Li X and Duchin K and Esteban D},
year = {2024},
journal = {Clinical and translational science},
doi = {10.1111/cts.13742},
url = {https://doi.org/10.1111/cts.13742}
}RIS
TY - JOUR TI - First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome. AU - Narayan R AU - Piérola AA AU - Donnellan WB AU - Yordi AM AU - Abdul-Hay M AU - Platzbecker U AU - Subklewe M AU - Kadia TM AU - Alonso-Domínguez JM AU - McCloskey J AU - Bradford K AU - Curtis M AU - Daskalakis N AU - Guttke C AU - Safer K AU - Hiebert B AU - Murphy J AU - Li X AU - Duchin K AU - Esteban D PY - 2024 JO - Clinical and translational science DO - 10.1111/cts.13742 UR - https://doi.org/10.1111/cts.13742 ER -
APA
R, N., AA, P., WB, D., AM, Y., M, A., U, P., M, S., TM, K., JM, A., J, M., K, B., M, C., N, D., C, G., K, S., B, H., J, M., X, L., K, D., & D, E. (2024). First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.. Clinical and translational science. https://doi.org/10.1111/cts.13742
Source records
- pubmed · retrieved 2026-09-26T01:54:09.373Z